Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
0.1849
+0.0069 (3.88%)
At close: Apr 1, 2025, 4:00 PM
0.1780
-0.0069 (-3.73%)
After-hours: Apr 1, 2025, 4:37 PM EDT

Ernexa Therapeutics Statistics

Total Valuation

ERNA has a market cap or net worth of $9.66 million. The enterprise value is $8.25 million.

Market Cap 9.66M
Enterprise Value 8.25M

Important Dates

The next estimated earnings date is Tuesday, May 13, 2025, after market close.

Earnings Date May 13, 2025
Ex-Dividend Date n/a

Share Statistics

ERNA has 52.24 million shares outstanding. The number of shares has increased by 156.81% in one year.

Current Share Class 52.24M
Shares Outstanding 52.24M
Shares Change (YoY) +156.81%
Shares Change (QoQ) +609.02%
Owned by Insiders (%) 48.66%
Owned by Institutions (%) 4.33%
Float 16.74M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 4.17
Forward PS n/a
PB Ratio 5.38
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 14.18
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.80, with a Debt / Equity ratio of 0.40.

Current Ratio 0.80
Quick Ratio 0.74
Debt / Equity 0.40
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -2.55

Financial Efficiency

Return on equity (ROE) is -2,264.31% and return on invested capital (ROIC) is -46.41%.

Return on Equity (ROE) -2,264.31%
Return on Assets (ROA) -39.64%
Return on Invested Capital (ROIC) -46.41%
Return on Capital Employed (ROCE) -740.03%
Revenue Per Employee $97,000
Profits Per Employee -$7.43M
Employee Count 6
Asset Turnover 0.02
Inventory Turnover n/a

Taxes

In the past 12 months, ERNA has paid $30,000 in taxes.

Income Tax 30,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -92.30% in the last 52 weeks. The beta is 7.33, so ERNA's price volatility has been higher than the market average.

Beta (5Y) 7.33
52-Week Price Change -92.30%
50-Day Moving Average 0.32
200-Day Moving Average 0.98
Relative Strength Index (RSI) 29.14
Average Volume (20 Days) 174,246

Short Selling Information

The latest short interest is 369,164, so 0.71% of the outstanding shares have been sold short.

Short Interest 369,164
Short Previous Month 348,163
Short % of Shares Out 0.71%
Short % of Float 2.20%
Short Ratio (days to cover) 1.23

Income Statement

In the last 12 months, ERNA had revenue of $582,000 and -$44.56 million in losses. Loss per share was -$3.26.

Revenue 582,000
Gross Profit 486,000
Operating Income -17.25M
Pretax Income -22.90M
Net Income -44.56M
EBITDA -17.11M
EBIT -17.25M
Loss Per Share -$3.26
Full Income Statement

Balance Sheet

The company has $1.73 million in cash and $684,000 in debt, giving a net cash position of $1.05 million or $0.02 per share.

Cash & Cash Equivalents 1.73M
Total Debt 684,000
Net Cash 1.05M
Net Cash Per Share $0.02
Equity (Book Value) 1.70M
Book Value Per Share 0.03
Working Capital -586,000
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$15.84 million and capital expenditures -$369,000, giving a free cash flow of -$16.21 million.

Operating Cash Flow -15.84M
Capital Expenditures -369,000
Free Cash Flow -16.21M
FCF Per Share -$0.31
Full Cash Flow Statement

Margins

Gross Margin 83.51%
Operating Margin -2,963.92%
Pretax Margin -7,647.59%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ERNA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -156.81%
Shareholder Yield n/a
Earnings Yield -479.11%
FCF Yield -174.25%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

The last stock split was on October 17, 2022. It was a reverse split with a ratio of 0.05:1.

Last Split Date Oct 17, 2022
Split Type Reverse
Split Ratio 0.05:1

Scores

ERNA has an Altman Z-Score of -70.19 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -70.19
Piotroski F-Score 3